|
Real-time
Euronext Paris
06:09:41 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 74.14 EUR | -0.75% |
|
-3.97% | -10.42% |
| 05:17am | RBC Launches Sanofi Coverage at Sector Perform Amid Management Turnaround, 'Light' Near-term Catalysts | MT |
| 04:10am | RBC Capital's view on Europe's major drugmakers |
Company Valuation: Sanofi
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 111,194 | 112,665 | 112,549 | 116,968 | 100,655 | 89,496 | - | - |
| Change | - | 1.32% | -0.1% | 3.93% | -13.95% | -11.09% | - | - |
| Enterprise Value (EV) 1 | 121,177 | 119,102 | 120,342 | 125,740 | 111,663 | 100,953 | 97,800 | 94,336 |
| Change | - | -1.71% | 1.04% | 4.49% | -11.2% | -9.59% | -3.12% | -3.54% |
| P/E | 17.8x | 16.7x | 20.8x | 20.4x | 12.9x | 11.9x | 10.4x | 8.95x |
| PBR | 1.62x | 1.5x | 1.52x | 1.51x | 1.41x | 1.21x | 1.14x | 1.08x |
| PEG | - | 2.07x | -1.1x | 3.14x | 0.3x | -6.53x | 0.7x | 0.6x |
| Capitalization / Revenue | 2.94x | 2.62x | 2.61x | 2.85x | 2.31x | 1.88x | 1.76x | 1.68x |
| EV / Revenue | 3.21x | 2.77x | 2.79x | 3.06x | 2.56x | 2.12x | 1.93x | 1.77x |
| EV / EBITDA | 9.95x | 8.14x | 8.44x | 9.76x | 8.22x | 6.85x | 6.24x | 5.55x |
| EV / EBIT | 11.3x | 9.13x | 9.5x | 11.1x | 9.19x | 7.64x | 7.02x | 6.24x |
| EV / FCF | 15x | 14x | 14.2x | 21.1x | 13.8x | 12.2x | 10.9x | 9.38x |
| FCF Yield | 6.68% | 7.12% | 7.04% | 4.74% | 7.24% | 8.23% | 9.21% | 10.7% |
| Dividend per Share 2 | 3.33 | 3.56 | 3.76 | 3.92 | 4.12 | 4.254 | 4.499 | 4.797 |
| Rate of return | 3.76% | 3.96% | 4.19% | 4.18% | 4.98% | 5.7% | 6.02% | 6.42% |
| EPS 2 | 4.97 | 5.37 | 4.31 | 4.59 | 6.4 | 6.283 | 7.205 | 8.343 |
| Distribution rate | 67% | 66.3% | 87.2% | 85.4% | 64.4% | 67.7% | 62.4% | 57.5% |
| Net sales 1 | 37,761 | 42,997 | 43,070 | 41,081 | 43,626 | 47,655 | 50,756 | 53,238 |
| EBITDA 1 | 12,183 | 14,627 | 14,259 | 12,889 | 13,583 | 14,737 | 15,679 | 16,992 |
| EBIT 1 | 10,714 | 13,040 | 12,670 | 11,343 | 12,149 | 13,221 | 13,930 | 15,115 |
| Net income 1 | 6,223 | 6,720 | 5,400 | 5,744 | 7,813 | 7,629 | 8,930 | 10,366 |
| Net Debt 1 | 9,983 | 6,437 | 7,793 | 8,772 | 11,008 | 11,457 | 8,304 | 4,840 |
| Reference price 2 | 88.58 | 89.84 | 89.76 | 93.74 | 82.72 | 74.70 | 74.70 | 74.70 |
| Nbr of stocks (in thousands) | 1,255,293 | 1,254,060 | 1,253,891 | 1,247,793 | 1,216,810 | 1,198,069 | - | - |
| Announcement Date | 2/4/22 | 2/3/23 | 2/1/24 | 1/30/25 | 1/29/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 11.89x | 2.12x | 6.85x | 5.7% | 104B | ||
| 31.99x | 11.64x | 23.74x | 0.62% | 1,002B | ||
| 29.94x | - | - | 2% | 649B | ||
| 31.86x | 7.4x | 15.38x | 2.76% | 440B | ||
| 19.06x | 4.64x | 11.51x | 2.86% | 346B | ||
| 19.62x | 5.13x | 12.72x | 3.16% | 263B | ||
| 20.69x | 4.25x | 12.14x | 2.08% | 250B | ||
| 24.87x | 6.52x | 11.97x | 2.57% | 213B | ||
| 13.02x | 4.72x | 9.85x | 3.87% | 201B | ||
| -44.81x | 6.47x | 25.27x | 2.25% | 182B | ||
| Average | 15.81x | 5.88x | 14.38x | 2.78% | 364.78B | |
| Weighted average by Cap. | 22.86x | 7.56x | 16.91x | 2.13% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SAN Stock
- Valuation Sanofi
Select your edition
All financial news and data tailored to specific country editions
















